NOTCH2NLC Intermediate-Length Repeat Expansions Are Associated with Parkinson Disease.
Chang-He ShiYu FanJing YangYan-Peng YuanSi ShenFen LiuCheng-Yuan MaoHan LiuShuo ZhangZheng-Wei HuLi-Yuan FanMeng-Jie LiShi-Heng FanXiao-Jing LiuYu-Ming XuPublished in: Annals of neurology (2020)
NOTCH2NLC GGC repeat expansions were recently identified in neuronal intranuclear inclusion disease (NIID); however, it remains unclear whether they occur in other neurodegenerative disorders. This study aimed to investigate the role of intermediate-length NOTCH2NLC GGC repeat expansions in Parkinson disease (PD). We screened for GGC repeat expansions in a cohort of 1,011 PD patients and identified 11 patients with intermediate-length repeat expansions ranging from 41 to 52 repeats, with no repeat expansions in 1,134 controls. Skin biopsy revealed phospho-alpha-synuclein deposition, confirming the PD diagnosis in 2 patients harboring intermediate-length repeat expansions instead of NIID or essential tremor. Fibroblasts from PD patients harboring intermediate-length repeat expansions revealed NOTCH2NLC upregulation and autophagic dysfunction. Our results suggest that intermediate-length repeat expansions in NOTCH2NLC are potentially associated with PD. ANN NEUROL 2021;89:182-187.
Keyphrases
- parkinson disease
- end stage renal disease
- ejection fraction
- deep brain stimulation
- affordable care act
- newly diagnosed
- cell proliferation
- chronic kidney disease
- oxidative stress
- healthcare
- peritoneal dialysis
- cell death
- poor prognosis
- patient reported outcomes
- health insurance
- brain injury
- cerebral ischemia
- fine needle aspiration